Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,862 | -3,804 | -15,385 | -10,642 | -6,856 |
| Depreciation Amortization | 983 | 492 | 1,611 | 1,029 | 570 |
| Income taxes - deferred | N/A | N/A | -1,651 | N/A | N/A |
| Accounts payable and accrued liabilities | 348 | 409 | 191 | 232 | -41 |
| Other Working Capital | 332 | 77 | -24 | 239 | -329 |
| Other Operating Activity | 3,929 | 306 | 5,308 | 1,924 | 1,481 |
| Operating Cash Flow | $-5,270 | $-2,520 | $-9,950 | $-7,218 | $-5,175 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | -2 | -4 | -3 |
| Net Acquisitions | N/A | N/A | -573 | -573 | N/A |
| Other Investing Activity | 0 | 0 | 729 | 716 | -1 |
| Investing Cash Flow | $-1 | $0 | $154 | $139 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | -112 | 25,008 | 10,000 | 10,000 |
| Other Financing Activity | 825 | 400 | -838 | 0 | 0 |
| Financing Cash Flow | $825 | $288 | $24,170 | $10,000 | $10,000 |
| Beginning Cash Position | 17,135 | 17,135 | 2,761 | 2,761 | 2,761 |
| End Cash Position | 12,593 | 14,901 | 17,135 | 5,682 | 7,582 |
| Net Cash Flow | $-4,542 | $-2,232 | $14,374 | $2,921 | $4,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,270 | -2,520 | -9,950 | -7,218 | -5,175 |
| Capital Expenditure | -1 | 0 | -2 | -4 | -3 |
| Free Cash Flow | -5,271 | -2,520 | -9,952 | -7,222 | -5,178 |